About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 9034 record(s)
Req # A-2023-00031
All import/export records and related cultural permits from {2001 to present (December 15, 2023)} conducted by the following businesses: 1. Canada Fossils Ltd.; 2. Canada Fossils 3. Korite lnternational 4. Korite lnternational Ltd. 5. Korite Minerals Ltd. 6. Korite USA Ltd. 7. Korite USA lnc. 8. Korite USA Ltd. lnc.Organization: Administrative Tribunals Support Service of Canada
April 2024
Req # A-2023-00044
Data related to EI parental benefit recipients. 1. the number of men and women who appealed their Service Canada decision to the Tribunal’s General Division (SST-GD) because they were denied the opportunity to change their election from standard parental benefits to extended parental benefits. 2. the number of appeals to SST-GD that were allowed (successful). 3. the number of appeals to SST-Appeal Division (SST-AD) regarding changing election from standard parental benefits to extended parental benefitsOrganization: Administrative Tribunals Support Service of Canada
April 2024
Req # EA2024_0065724
Provide the work description in both official languages for the President and CEO of the Halifax Port Authority in addition to all records of business value concerning how the position's linguistic profile was identified.Organization: Halifax Port Authority
April 2024
Req # N/A - Request received via delivery
Please provide all records relating to the procurement of Public Affairs, Government Relations, and Communications services for the period from January 1, 2023 to the current date. This will include the name of the individuals or companies from whom services were procured, the amount of the contract for services and copies of any related contracts and invoices. Additionally, please confirm whether contracts were sole-sourced from a standing offer list or subject to a competitive process. If a competitive process was utilized, please confirm what process was used, the date of the contract award and the number of respondents for each procurement.Organization: Halifax Port Authority
April 2024
Req # A-2023-00022
Budget documents that specify funding for the Canadian Human Rights Tribunal (CHRT) for the fiscal years 2015-16 to 2022-23 inclusive.Organization: Administrative Tribunals Support Service of Canada
March 2024
Req # A-2023-00043
The number of applications/cases/hearings concerning the Canadian Security Intelligence Service heard/filed at the Federal Public Sector Labour Relations and Employment Board (FPSLREB) in the last three (3) years, from January 2021 to January 2024.Organization: Administrative Tribunals Support Service of Canada
March 2024
Req # A-2023-00042
Machine-readable, itemized database, spreadsheet or dump/export of all works by the painter Norval Morrisseau submitted to CCPERB for certification. The record should include the assessed value, title and date of each work.Organization: Administrative Tribunals Support Service of Canada
March 2024
Req # A-2016-000420
Documents relating to Health Canada’s approval of INFLECTRA (Drug Identification Number (DIN) # 02419475): All Health Canada reviewers reports and reviewer comments; and all minutes from any pre-Supplement to a New Drug Submission (SNDS) meetings between Celltrion (health care company) and Health Canada between September 1, 2014 and June 30, 2015.Organization: Health Canada
March 2024
Req # A-2019-001464
All domestic Adverse Drug Reaction (ADR) reports for Tetanus, Diphtheria and Pertussis (Tdap) Hepatitis B, Measles, Mumps and Rubella (MMR), Varicelli, Inactivated Polio Vaccine (IPV), Diphtheria, Tetanus and Pertussis (DTaP), Flu for the period of October 1, 2018 - end of March 2019.Organization: Health Canada
March 2024
Req # A-2019-001525
The Clinical Overview, Clinical Summary of Efficacy and Clinical Summary of Safety submitted to Health Canada as part of the Supplemental New Drug Submission (SNDS) (control number: 204690; decision date: 2018-03-29) in respect of TALTZ.Organization: Health Canada
March 2024